Saumendra N Sarkar

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 16

Top Venues

Cancer immunology research

Cancer research

eLife

Journal of immunology (Baltimore, Md. : 1950)

University of Pittsburgh

Indian Institute of Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pittsburgh

United States

Associate Prof. :: Microbiology and Molecular Genetics

Education History

Indian Institute of Science Aug 01 1990 - Jun 30 1995

India

PHD :: Molecular Biophysics

Publications

Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance. Cancer immunology research 12 (6) (2024)
Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T cells and Promotes Tumor Clearance. Cancer immunology research (2024)
Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance. Cancer immunology research 12 (6) (2024)
Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T cells and Promotes Tumor Clearance. Cancer immunology research (2024)
Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T cells and Promotes Tumor Clearance. Cancer immunology research (2024)
Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance. Cancer immunology research 12 (6) (2024)
Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance. Cancer immunology research 12 (6) (2024)
Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance. Cancer immunology research 12 (6) (2024)
Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance. Cancer immunology research 12 (6) (2024)
Lulu Shao, Rashmi Srivastava, Greg M Delgoffe, Stephen H Thorne, Saumendra N Sarkar
An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance. Cancer immunology research 12 (6) (2024)
Saumendra N Sarkar, Munesh K Harioudh, Lulu Shao, Joseph Perez, Arundhati Ghosh
The Many Faces of Oligoadenylate Synthetases. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research (2023)
Frank W Soveg, Johannes Schwerk, Nandan S Gokhale, Karen Cerosaletti, Julian R Smith, Erola Pairo-Castineira, Alison M Kell, Adriana Forero, Shivam A Zaver, Katharina Esser-Nobis, Justin A Roby, Tien-Ying Hsiang, Snehal Ozarkar, Jonathan M Clingan, Eileen T McAnarney, Amy E L Stone, Uma Malhotra, Cate Speake, Joseph Perez, Chiraag Balu, Eric J Allenspach, Jennifer L Hyde, Vineet D Menachery, Saumendra N Sarkar, Joshua J Woodward, Daniel B Stetson, John Kenneth Baillie, Jane H Buckner, Michael Gale, Ram Savan
Endomembrane targeting of human OAS1 p46 augments antiviral activity. eLife 10 (2021)
Lulu Shao, Weizhou Hou, Nicole E Scharping, Frank P Vendetti, Rashmi Srivastava, Chandra Nath Roy, Ashley V Menk, Yiyang Wang, Joe-Marc Chauvin, Pooja Karukonda, Stephen H Thorne, Veit Hornung, Hassane M Zarour, Christopher J Bakkenist, Greg M Delgoffe, Saumendra N Sarkar
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell. Cancer immunology research 7 (8) (2019)
Marie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N Sarkar, Brian Orr, Ravikumar Muthuswamy, Jamie Voyten, Francesmary Modugno, Weijian Jiang, Melissa Grimm, Per H Basse, David L Bartlett, Robert P Edwards, Pawel Kalinski
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment. Cancer research 78 (15) (2018)
Rolando A Cuevas, Arundhati Ghosh, Christina Wallerath, Veit Hornung, Carolyn B Coyne, Saumendra N Sarkar
MOV10 Provides Antiviral Activity against RNA Viruses by Enhancing RIG-I-MAVS-Independent IFN Induction. Journal of immunology (Baltimore, Md. : 1950) 196 (9) (2016)
Madhavi K Ganapathiraju, Mohamed Thahir, Adam Handen, Saumendra N Sarkar, Robert A Sweet, Vishwajit L Nimgaonkar, Christine E Loscher, Eileen M Bauer, Srilakshmi Chaparala
Schizophrenia interactome with 504 novel protein-protein interactions. NPJ schizophrenia 2 (2016)

Saumendra N Sarkar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Saumendra N Sarkar